|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 21 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
238,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
AS |
$89.70 |
$448,500 |
D/D |
(5,000) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$602,381 |
D/D |
(6,640) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-05 |
4 |
AS |
$90.56 |
$452,800 |
D/D |
(5,000) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-05 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
231,924 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2017-06-13 |
4 |
B |
$3.00 |
$48,069 |
D/D |
16,000 |
55,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-09-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
430 |
226,494 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-09-29 |
4 |
A |
$116.74 |
$14,476 |
D/D |
124 |
4,916 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-28 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
235,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-28 |
4 |
AS |
$89.89 |
$898,912 |
D/D |
(10,000) |
225,894 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-12-29 |
4 |
A |
$94.71 |
$14,491 |
D/D |
153 |
5,069 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-29 |
4 |
AS |
$89.61 |
$896,125 |
D/D |
(10,000) |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-29 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
235,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-01-05 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
235,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-01-05 |
4 |
AS |
$90.32 |
$903,203 |
D/D |
(10,000) |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-02-15 |
4 |
AS |
$84.63 |
$846,285 |
D/D |
(10,000) |
226,494 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-02-15 |
4 |
OE |
$38.59 |
$385,900 |
D/D |
10,000 |
236,494 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,722 |
272,216 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-02 |
4 |
D |
$79.86 |
$682,164 |
D/D |
(8,542) |
264,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-02 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
273,216 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
OE |
$38.59 |
$578,850 |
D/D |
15,000 |
279,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
AS |
$84.73 |
$1,270,901 |
D/D |
(15,000) |
264,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
D |
$83.57 |
$1,245,862 |
D/D |
(14,908) |
249,766 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
46,340 |
296,106 |
0 |
- |
|
850 Records found
|
|
Page 21 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|